While most evidence shows that PPARγ expression increases in diabetic or obesity models of NAFLD [48] and suggest a deleterious and lipogenic role for hepatic PPARγ in NAFLD [49], others suggest a beneficial role for PPARγ [50,51]. The gene discussed is PPARG; the disease is obesity disorder.